REVIVA PHARMACEUTICALS HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.99 USD | +0.34% |
|
-0.99% | -41.94% |
Chart calendar Reviva Pharmaceuticals Holdings, Inc.
5cb87ea8a89d425b0.UJ9D7k7vUUR91Sy8WXcBq9CHKWpuEQmM8HmeasKsVsE.Pep3oHndYRwRth3TIB9px57jHhNDJ2y6vhOrEqj5P7Yy-CiZIYEVFRG8eQ~0dc20c5f28ad7f8fa21038a709faef1b
Upcoming events on Reviva Pharmaceuticals Holdings, Inc.
Past events on Reviva Pharmaceuticals Holdings, Inc.
| 2024-04-15 08:05 | Q4 2023 Earnings Release |
| 2024-04-04 06:00 | Schizophrenia International Research Society Meeting - Poster No : T291 |
| 2024-04-04 04:25 | Schizophrenia International Research Society Meeting |
| 2024-03-27 19:00 | American Society for Clinical Pharmacology & Therapeutics Meeting |
| 2024-03-19 17:00 | Roth Conference |
| 2024-03-18 13:30 | UBS Virtual CNS Day |
| 2024-02-26 14:45 | BIO CEO & Investor Conference |
| 2024-02-15 12:00 | Investor Meeting - key Opinion Leader |
| 2024-02-01 12:30 | Lytham Partners Investor Select Conference - Fireside Chat |
| 2024-01-17 15:00 | Webull Live Virtual Healthcare Investment Conference |
| 2023-12-14 12:00 | Life Sciences Investor Forum |
| 2023-12-06 | Benchmark Company Discovery Conference |
| 2023-11-14 16:01 | Q3 2023 Earnings Release |
| 2023-11-13 14:00 | Annual General Meeting |
| 2023-10-30 08:30 | Phase 3 RECOVER Topline Results Conference Call |
| 2023-09-12 15:30 | H.C. Wainwright Global Investment Conference - Panel |
| 2023-09-11 13:30 | H.C. Wainwright Global Investment Conference |
| 2023-08-14 16:01 | Q2 2023 Earnings Release |
| 2023-08-10 10:00 | Canaccord Genuity Growth Conference |
| 2023-08-08 14:00 | BTIG Virtual Biotechnology Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,43 -2,33 -4.54% | -10,1 -10,4 3.12% | -24,3 -21,0 -15.56% | -39,5 -38,6 -2.22% | -39,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,78 -2,80 -35.14% | -8,52 -9,15 6.97% | -24,3 -20,8 -16.96% | -39,2 -37,5 -4.64% | -37,1 |
|
Net income Million USD | Released Forecast Spread | -3,78 -2,80 -35.12% | -8,52 -9,16 6.98% | -24,3 -20,9 -16.41% | -39,3 -38,6 -1.75% | -37,1 |
|
EPS USD | Released Forecast Spread | -1,24 -0,17 -629.41% | -0,58 -0,63 8.42% | -1,25 -1,09 -14.94% | -1,65 -1,58 -4.21% | -1,46 |
| Announcement Date | 22/03/21 | 15/03/22 | 30/03/23 | 15/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,96 -4,03 1.67% | -7,45 -4,49 -66.02% | -5,52 -6,64 16.85% | -3,56 -5,76 38.16% | -7,77 -4,50 -72.73% | -6,74 -7,35 8.4% | -12,1 -6,54 -84.51% | -10,7 -8,78 -22.01% | -9,99 -9,14 -9.33% | -10,1 | -9,85 | -10,8 | -12,1 | -13,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,68 -4,32 14.79% | -7,36 -4,49 -64.04% | -5,33 -6,64 19.65% | -3,51 -5,84 39.86% | -8,11 -4,33 -87.11% | -6,60 -7,30 9.63% | -12,4 -6,41 -94.1% | -10,5 -7,99 -31.09% | -9,73 -7,99 -21.71% | -10,2 | -9,93 | -10,8 | -12,1 | -13,6 |
|
Net income Million USD | Released Forecast Spread | -3,68 -4,33 14.8% | -7,37 -4,49 -64.09% | -5,34 -6,64 19.54% | -3,52 -5,84 39.83% | -8,12 -4,33 -87.3% | -6,60 -7,30 9.59% | -12,4 -6,41 -94.16% | -10,5 -8,00 -31.21% | -9,72 -8,00 -21.63% | -10,2 | -9,93 | -10,8 | -12,1 | -13,6 |
|
EPS USD | Released Forecast Spread | -0,22 -0,25 12% | -0,40 -0,25 -60% | -0,29 -0,35 17.14% | -0,18 -0,30 40% | -0,38 -0,22 -75.38% | -0,30 -0,31 1.64% | -0,55 -0,29 -89.66% | -0,44 -0,32 -36.65% | -0,35 -0,31 -12.9% | -0,37 | -0,35 | -0,36 | -0,38 | -0,42 |
| Announcement Date | 15/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 15/04/24 | - | - | - | - | - |
More events
Past sector events for Reviva Pharmaceuticals Holdings, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RVPH Stock
- Calendar Reviva Pharmaceuticals Holdings, Inc.
